- CA$52.68m
- CA$97.21m
- $36.00m
- 65
- 81
- 50
- 73
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.53 | ||
| Price to Tang. Book | 7.78 | ||
| Price to Free Cashflow | 9.5 | ||
| Price to Sales | 0.98 | ||
| EV to EBITDA | 10.07 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -7.59% | ||
| Return on Equity | -24.12% | ||
| Operating Margin | -22.25% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 25.19 | 37.24 | 35.41 | 34.81 | 36 | 51.46 | 69.58 | 10.03% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -61.35 | -28.46 | +102.64 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Vext Science, Inc. is a cannabis operator with vertical operations in Arizona and Ohio. The Company's expertise spans from cultivation through to retail operations in its key markets. The Company owns and operates cultivation facilities, fully built-out manufacturing facilities as well as dispensaries in both Arizona and Ohio. The Company produces a range of branded offerings, including its Vapen, Revibe, Herbal Wellness Center, and Appalachian Pharm lines. The Company manufactures Vapen, one of the THC concentrates, edibles, and distillate cartridge brands in Arizona. It produces CBD products under the Vapen CBD and Hempy Endings brands, manufactured at its Vapen Kentucky facility. Through strategic licensing agreements, it manufactures the Microbar brand in Arizona. The Company extends its services to the cannabis industry by offering management, advisory, cultivation, non-cannabis products, and dispensary services through operating agreements and direct sales to various entities.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- December 11th, 2015
- Public Since
- May 13th, 2019
- No. of Employees
- 173
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Canadian Securities Exchange- Shares in Issue
- 309,877,856
- Address
- 4152 N. 39Th Avenue, PHOENIX, 85019
- Web
- https://www.vextscience.com/overview/default.aspx
- Phone
- +1 6046889588
- Auditors
- Reliant CPA PC
Upcoming Events for VEXT
Q3 2025 Vext Science Inc Earnings Release
Vext Science Inc Annual Shareholders Meeting
Similar to VEXT
4Front Ventures
Canadian Securities Exchange
Ascend Wellness Holdings
Canadian Securities Exchange
Ayr Wellness
Canadian Securities Exchange
Braxia Scientific
Canadian Securities Exchange
Craftport Cannabis
Canadian Securities Exchange
FAQ
What is the Vext Science share price?
As of Today at 23:58 UTC, shares in Vext Science are trading at CA$0.17. This share price information is delayed by 15 minutes.
How has the Vext Science share price performed this year?
Shares in Vext Science last closed at CA$0.17 and the price had moved by -26.09% over the past 365 days. In terms of relative price strength the Vext Science share price has underperformed the Toronto Stock Exchange 300 Composite Index by -37.98% over the past year.
What are the analyst and broker recommendations for Vext Science?
The overall consensus recommendation for Vext Science is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Vext Science dividend yield?
Vext Science does not currently pay a dividend.
Does Vext Science pay a dividend?
Vext Science does not currently pay a dividend.
When does Vext Science next pay dividends?
Vext Science does not currently pay a dividend.
How do I buy Vext Science shares?
To buy shares in Vext Science you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Vext Science?
As of the previous close price of CA$0.17, shares in Vext Science had a market capitalisation of CA$52.68m.
Where are Vext Science shares listed?
Here are the trading details for Vext Science:
- Country of listing: Canada
- Exchange: CNX
- Ticker Symbol: VEXT
What kind of share is Vext Science?
Based on an overall assessment of its quality, value and momentum Vext Science is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Vext Science share price forecast for 2025?
The analyst consensus target price for shares in Vext Science is CA$0.52. That is 205.21% above the last closing price of CA$0.17.
Analysts covering Vext Science currently have a consensus Earnings Per Share (EPS) forecast of -$0.05 for the next financial year.
Find out moreWhat is the trend in the Vext Science share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vext Science. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -9.2%.
As of the last closing price of CA$0.17, shares in Vext Science were trading +1.08% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Vext Science PE Ratio?
The Vext Science PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.17.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Vext Science?
We do not have data on Vext Science's directors